By NewsDesk @bactiman63
German health officials decided to resume the use of the AstraZeneca COVID-19 vaccine Friday after the European Medicines Agency (EMA) reported Thursday that the benefits of getting the COVID-19 Vaccine AstraZeneca still outweigh the risks.
“We have to remain cautious, prudent and pragmatic: with the decisions on AstraZeneca we did just that,” said Federal Health Minister Jens Spahn on Friday at the federal press conference. As a precautionary measure, the vaccination was suspended after the Paul Ehrlich Institute recommended this procedure due to a number of worrying events.”
SPD health expert Prof. Dr. Karl Lauterbach welcomes the fact that AstraZeneca is being vaccinated again: “From the patient’s perspective, the cost-benefit ratio of this vaccine is excellent. The complication occurs in less than 1 in 100,000 patients. ”The benefit of the vaccine has been proven particularly in large field studies. He could very safely prevent hospitalization and death in the elderly. “It is not a second-class vaccine,” said Lauterbach.
Meanwhile, the number of infections is rising again significantly: “We are in the third wave of the pandemic. So there are still quite challenging weeks ahead of us. Vaccination is a key step here, but it takes time.”
The number of confirmed coronavirus cases in Germany increased by 16,033 to 2,645,783, according to data from the Robert Koch Institute (RKI).
The reported death toll rose by 207 to 74,565.
Every 10th adult in Germany is now vaccinated.
- Parasites treatment: Ivermectin is safe and well tolerated in young children
- Norway will keep use of the AstraZeneca vaccine on hold as review continues
- 114 new COVID-19 cases in Philippines linked to new virus variants
- New research shows listeriosis in England, Wales still prevalent albeit decreasing
- Cambodia COVID-19 community outbreak tallies 53 new cases
- COVID-19 cases in PH peak new at over 7,000 cases
- Philippines to receive 3M doses of Sputnik V vaccine from EUA grant